Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,020 | -8,360 | -11,010 | -4,130 | -9,080 |
| Depreciation Amortization | 120 | 570 | 240 | 310 | 300 |
| Other Working Capital | -650 | 50 | 640 | 1,460 | 9,270 |
| Other Operating Activity | 160 | -10 | 1,630 | -6,680 | -310 |
| Operating Cash Flow | $-10,390 | $-7,750 | $-8,500 | $-9,040 | $180 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -30 | -10 | -150 | -630 |
| Other Investing Activity | 3,005 | -10,110 | -6,420 | 1,150 | -3,240 |
| Investing Cash Flow | $3,000 | $-10,140 | $-6,430 | $1,000 | $-3,870 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 22,490 | 14,960 | -630 | 0 | 350 |
| Financing Cash Flow | $22,490 | $14,960 | $-630 | $0 | $350 |
| Exchange Rate Effect | 0 | 50 | 290 | 3 | -40 |
| Beginning Cash Position | 870 | 3,750 | 19,030 | 27,060 | 30,440 |
| End Cash Position | 15,980 | 870 | 3,750 | 19,030 | 27,060 |
| Net Cash Flow | $15,110 | $-2,870 | $-15,270 | $-8,030 | $-3,380 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,390 | -7,750 | -8,500 | -9,040 | 180 |
| Free Cash Flow | -10,390 | -7,750 | -8,500 | -9,040 | 180 |